Bolt
Biotechnology ResearchCalifornia, United States11-50 Employees
Inspired by Nature, designing for our future. Nasdaq ticker: $BSLK Forward looking statements notice: https://bolt-bslk.com/forward-looking-statements/
Innovative Immunotherapies Bolt is developing cutting-edge immunotherapeutic agents targeting cancer, such as BDC-4182, which shows promising immune responses. Opportunities exist to explore licensing, partnership, or distribution agreements to expand the reach of their next-generation treatments.
Clinical Progress & Expansion With ongoing Phase 1 trials in multiple countries and initial data supporting protocol modifications, Bolt is positioned for international clinical expansion. Business development prospects include clinical trial collaborations and research support services.
Funding & Revenue Growth Bolt has generated revenue between $10M and $25M and secured funding of $4.3M, indicating a solid financial base for further product development and commercialization efforts. Partnerships or investment opportunities could accelerate their pipeline progress.
Strategic Pipeline Focus Key pipeline candidates like BDC-4182 and BDC-3042 target valuable oncology markers, creating opportunities to co-develop or license these candidates with pharma companies seeking innovative cancer therapies.
Technological & Data Capabilities Bolt's integration of advanced biotech tools and clinical data provides a platform for potential collaborations with service providers or technology partners focused on biopharma R&D acceleration and precision medicine.
Bolt uses 8 technology products and services including Impact, RSS, jQuery Migrate, and more. Explore Bolt's tech stack below.
| Bolt Email Formats | Percentage |
| FLast@boltthreads.com | 87% |
| Last@boltthreads.com | 5% |
| First.Last@boltthreads.com | 4% |
| First@boltthreads.com | 3% |
| FMiddleLast@boltthreads.com | 1% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Inspired by Nature, designing for our future. Nasdaq ticker: $BSLK Forward looking statements notice: https://bolt-bslk.com/forward-looking-statements/
Bolt has raised a total of $4.3M of funding over 8 rounds. Their latest funding round was raised on Aug 14, 2025 in the amount of $4.3M.
Bolt's revenue is estimated to be in the range of $10M$25M
Bolt has raised a total of $4.3M of funding over 8 rounds. Their latest funding round was raised on Aug 14, 2025 in the amount of $4.3M.
Bolt's revenue is estimated to be in the range of $10M$25M